Neuland Laboratories EBITDA margin
¿Qué es el EBITDA margin de Neuland Laboratories?
El EBITDA margin de Neuland Laboratories Limited es 14.85%
¿Cuál es la definición de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de compañías en Sector Health Care en BSE en comparadas con Neuland Laboratories
¿Qué hace Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Empresas con ebitda margin similar a Neuland Laboratories
- Ferro tiene EBITDA margin de 14.83%
- IPL Plastics tiene EBITDA margin de 14.83%
- BBX Capital tiene EBITDA margin de 14.84%
- Entain PLC tiene EBITDA margin de 14.84%
- Rajkumar Forge tiene EBITDA margin de 14.84%
- Zix tiene EBITDA margin de 14.84%
- Neuland Laboratories tiene EBITDA margin de 14.85%
- Ponni Sugars (Erode) tiene EBITDA margin de 14.85%
- American Renal Associates tiene EBITDA margin de 14.86%
- Accel tiene EBITDA margin de 14.86%
- Colfax tiene EBITDA margin de 14.86%
- Jyothy Laboratories tiene EBITDA margin de 14.87%
- Smiths Plc tiene EBITDA margin de 14.87%